Question
Type of Ratio/ Years 2019-RM000.00 2020-RM000.00 2021-RM000.00 Current Ratio: Current Assets / Current Liabilities 417,205 / 239,442 = 1.74 459,693 / 150,321 = 3.06 494,796
| Type of Ratio/ Years | 2019-RM000.00 | 2020-RM000.00 | 2021-RM000.00 |
| Current Ratio: Current Assets / Current Liabilities | 417,205 / 239,442 = 1.74 | 459,693 / 150,321 = 3.06
| 494,796 / 230,309 = 2.15 |
| Quick Ratio: (Current Assets Inventories) / Current Liabilities | (417,205 - 144,003) / 239,442 = 1.14 | (459,693 - 151,266) / 150,321 = 2.05 | (494,796 - 222,192) / 230,309 = 1.18 |
| Cash Ratio: Cash and equivalent / Current liabilities | 120,669 / 239,442 = 0.50 | 158,029 / 230,309 = 0.69 | 137,980 / 150,321 = 0.92 |
| Net Working Capital Ratio: Current Assets Current Liabilities | 417,205 - 239,442 = 177,763 | 459,693 - 150,321 = 309,372
| 494,796 - 230,309 = 230,309 |
- Analysis of The Relevant Liquidity for Duopharma Biotech Berhad for the Ended 2019, 2020 and 2021:
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access with AI-Powered Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started
Advanced Accounting
Authors: Joe Hoyle, Thomas Schaefer, Timothy Doupnik
10th edition
0-07-794127-6, 978-0-07-79412, 978-0077431808
